Expired contract
PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme
Details
- Supplier(s)
- Costello Medical
- Value
- GBP 80,463.75
- Duration
- 1 year
- Topic
- Administrative healthcare services
- Published
- 17 August 2021
- Source
- uk:contracts_finder
Tender description
Minimum acceptable performance criteria for designing test accuracy studies of cfDNA within the UK Sickle Cell and Thalassaemia Screening Programme: a decision analytic model.
Timeline
- Completed: Award published17 August 2021Current notice
- Completed: Award date17 August 2021
- Completed: Contract expiry date30 December 2022
About the buyer
Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 75122000 · Administrative healthcare services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@public-health-england.gov |
3 similar open tenders
See more open tenders related to PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme.
- Open tender
Health and safety services
Related buyers
Buyers similar to Public Health England.
BuyersCountValue
- 2,594£1.6bn
- 1,683£204.6bn
- 880£19.4bn
- 677£8.8bn
- 461£15.4bn
- 423£3.8bn
- 339£20.2m
- 290£366.8m
- 256£233.2m
- 252£892.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
